Cancer screening

Cancer research

Adherence to Repeat Screening Completion for Colorectal Cancer Higher Among Patients with Medicare and Medicare Advantage

Investigators from Exact Sciences Corporation conducted a real-world study examining adherence to repeat multi-target stool DNA (mt-sDNA) testing among patients from federally qualified health centers (FQHCs) across the US. The research, published in the Journal of Primary Care & Community Health, analyzed data from 19,536 eligible patients who had

Cancer research

Substantial Improvement in Cancer Detection and Positive Predictive Value: PATHFINDER 2 Study Yields Encouraging Results

The GRAIL, Inc. has announced positive top-line performance and safety results from the PATHFINDER 2 study, a registrational study evaluating the safety and performance of the Galleri multi-cancer early detection (MCED) test. The study, initiated in 2021, has enrolled 25,578 participants and demonstrated substantial improvement in cancer detection and